The Food and Drug Administration on Thursday approved the first generic version of EpiPen, providing new competition that could help drive down the cost of a lifesaving product that had become a ...

State Medicaid and the State Health Plan will each receive $4.2 million from an $11 million settlement North Carolina has ...

Maryland reaches $4.5 million settlement with EpiPen makers ...

EpiPen will face competition in a generic version of the auto-injector marketed by Teva Pharmaceuticals and approved by the U.S. Food and Drug Administration on Thursday. The FDA previously approved ...

Maryland reached a $4.5 million settlement with EpiPen maker Mylan over anticompetitive conduct involving pricing and ...

Plaintiffs say Teva, Viatris, Pfizer entered into quid-pro-quo involving two drugs Viatris and Pfizer previously settled related allegations for combined $609 million (Reuters) - Teva Pharmaceutical ...

Responding to national outrage over high prices, Mylan announced plans on Monday to launch a generic EpiPen at a 50% discount to the branded version of the life saving allergy treatment. Mylan (MYL) ...

Mylan will make its generic to EpiPen available for purchase next week, according to npr. 1. The generic will cost half as much as EpiPen, carrying a list price of $300 for a two-pack. 2. In a ...

Mylan’s life-saving epinephrine auto-injector EpiPen now has a generic rival, the Food and Drug Administration (FDA) triumphantly announced. Teva Pharmaceuticals USA now has FDA approval to market a ...

NEW YORK (Reuters) - Many of the largest U.S. pharmacies and drug distributors do not have Teva Pharmaceutical Industries Ltd's generic version of the life-saving EpiPen allergy treatment five months ...